INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 149 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $274,000 | -11.0% | 6,611 | +3.0% | 0.03% | -10.3% |
Q2 2020 | $308,000 | -17.0% | 6,420 | +114.7% | 0.03% | -12.1% |
Q4 2019 | $371,000 | -29.6% | 2,990 | -62.3% | 0.03% | -36.5% |
Q3 2019 | $527,000 | -5.0% | 7,936 | +13.7% | 0.05% | -7.1% |
Q2 2019 | $555,000 | -4.3% | 6,979 | +34.5% | 0.06% | -9.7% |
Q1 2019 | $580,000 | +26.4% | 5,189 | +13.9% | 0.06% | +5.1% |
Q4 2018 | $459,000 | +4.6% | 4,554 | +31.1% | 0.06% | +18.0% |
Q3 2018 | $439,000 | +67.6% | 3,474 | +11.5% | 0.05% | +56.2% |
Q2 2018 | $262,000 | -25.6% | 3,117 | -45.5% | 0.03% | -30.4% |
Q1 2018 | $352,000 | +6.3% | 5,722 | +0.9% | 0.05% | +15.0% |
Q4 2017 | $331,000 | +14.1% | 5,672 | +136.8% | 0.04% | +5.3% |
Q2 2017 | $290,000 | +22.9% | 2,395 | +14.9% | 0.04% | +18.8% |
Q1 2017 | $236,000 | -8.5% | 2,085 | -12.0% | 0.03% | -15.8% |
Q4 2016 | $258,000 | -31.7% | 2,370 | +3.3% | 0.04% | -32.1% |
Q3 2016 | $378,000 | +17.4% | 2,295 | +1.5% | 0.06% | +5.7% |
Q2 2016 | $322,000 | +13.0% | 2,260 | +1.8% | 0.05% | +6.0% |
Q1 2016 | $285,000 | -8.9% | 2,220 | +6.0% | 0.05% | -12.3% |
Q4 2015 | $313,000 | -12.6% | 2,095 | -3.0% | 0.06% | -20.8% |
Q3 2015 | $358,000 | -31.5% | 2,160 | -0.4% | 0.07% | -25.8% |
Q2 2015 | $523,000 | -13.4% | 2,168 | +1.3% | 0.10% | -5.8% |
Q1 2015 | $604,000 | +74.6% | 2,140 | -3.4% | 0.10% | +94.3% |
Q4 2014 | $346,000 | – | 2,215 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |